RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chongqing Zhifei Biological Products Co Stock

Chongqing Zhifei Biological Products Co ROE 2024

Chongqing Zhifei Biological Products Co ROE

0.26

Ticker

300122.SZ

ISIN

CNE100000V20

In 2024, Chongqing Zhifei Biological Products Co's return on equity (ROE) was 0.26, a -17.66% increase from the 0.31 ROE in the previous year.

Chongqing Zhifei Biological Products Co Aktienanalyse

What does Chongqing Zhifei Biological Products Co do?

Chongqing Zhifei Biological Products Co Ltd is a Chinese company that was founded in 1998 and is headquartered in Chongqing, China. The company operates in the biotechnology sector and focuses on the research, development, and manufacturing of biological products. The company initially started in the 1990s as a small laboratory unit of Chongqing Lummy Pharmaceutical Co Ltd, a Chinese pharmaceutical company that mainly produced drugs. In 1998, the company decided to focus on the business of biological products and established Chongqing Zhifei Biological Products Co Ltd. The company's business model is based on the production of high-quality biopharmaceuticals and medical devices. Zhifei Biological Products offers a wide range of products such as vaccines, blood products, virus tests, medical devices, and diagnostic kits. The company has four main business fields: vaccines, blood products, test kits, and medical devices. Among vaccines, Zhifei Biological Products offers a range of vaccines for the prevention of infectious diseases such as hepatitis B, diphtheria, tetanus, and pertussis. The blood products manufactured by the company include intravenous immunoglobulins, plasma proteins, and albumin. Test kits include IgG antibody tests and quantitative PCR tests. Additionally, the company also offers a wide range of medical devices including blood collection kits, syringes, and infusion sets. The company has established itself in China as a trusted and reliable manufacturer of biopharmaceuticals and collaborates closely with various healthcare organizations to promote the prevention and control of infectious diseases. Zhifei Biological Products has also successfully exported its products to other countries and is active in the international market. In recent years, Zhifei Biological Products has also played a crucial role in the fight against the COVID-19 pandemic. The company, in collaboration with the Chinese military, developed and produced a COVID-19 vaccine in a short period of time. This vaccine has already been approved in countries such as Indonesia and Brazil and is being distributed worldwide. The company takes pride in not only manufacturing biopharmaceuticals but also contributing to creating a better world. It has a strong corporate culture and constantly promotes innovation and advanced technology. Chongqing Zhifei Biological Products Co Ltd is a key player in the Chinese biotechnology industry and plays an important role in improving global health. Chongqing Zhifei Biological Products Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Chongqing Zhifei Biological Products Co's Return on Equity (ROE)

Chongqing Zhifei Biological Products Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Chongqing Zhifei Biological Products Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Chongqing Zhifei Biological Products Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Chongqing Zhifei Biological Products Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Chongqing Zhifei Biological Products Co stock

What is the ROE (Return on Equity) of Chongqing Zhifei Biological Products Co this year?

The ROE of Chongqing Zhifei Biological Products Co this year is 0.26 undefined.

How has the Return on Equity (ROE) of Chongqing Zhifei Biological Products Co developed compared to the previous year?

The ROE of Chongqing Zhifei Biological Products Co has increased by -17.66% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Chongqing Zhifei Biological Products Co?

A high ROE indicates that Chongqing Zhifei Biological Products Co generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Chongqing Zhifei Biological Products Co?

A low ROE can indicate that Chongqing Zhifei Biological Products Co is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Chongqing Zhifei Biological Products Co affect the company?

A change in ROE (Return on Equity) of Chongqing Zhifei Biological Products Co can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Chongqing Zhifei Biological Products Co?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Chongqing Zhifei Biological Products Co?

Some factors that can influence Chongqing Zhifei Biological Products Co's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Chongqing Zhifei Biological Products Co pay?

Over the past 12 months, Chongqing Zhifei Biological Products Co paid a dividend of 0.33 CNY . This corresponds to a dividend yield of about 1.2 %. For the coming 12 months, Chongqing Zhifei Biological Products Co is expected to pay a dividend of 0.42 CNY.

What is the dividend yield of Chongqing Zhifei Biological Products Co?

The current dividend yield of Chongqing Zhifei Biological Products Co is 1.2 %.

When does Chongqing Zhifei Biological Products Co pay dividends?

Chongqing Zhifei Biological Products Co pays a quarterly dividend. This is distributed in the months of September, August, July, September.

How secure is the dividend of Chongqing Zhifei Biological Products Co?

Chongqing Zhifei Biological Products Co paid dividends every year for the past 16 years.

What is the dividend of Chongqing Zhifei Biological Products Co?

For the upcoming 12 months, dividends amounting to 0.42 CNY are expected. This corresponds to a dividend yield of 1.5 %.

In which sector is Chongqing Zhifei Biological Products Co located?

Chongqing Zhifei Biological Products Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chongqing Zhifei Biological Products Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chongqing Zhifei Biological Products Co from 8/8/2024 amounting to 0.8 CNY, you needed to have the stock in your portfolio before the ex-date on 8/8/2024.

When did Chongqing Zhifei Biological Products Co pay the last dividend?

The last dividend was paid out on 8/8/2024.

What was the dividend of Chongqing Zhifei Biological Products Co in the year 2023?

In the year 2023, Chongqing Zhifei Biological Products Co distributed 0.6 CNY as dividends.

In which currency does Chongqing Zhifei Biological Products Co pay out the dividend?

The dividends of Chongqing Zhifei Biological Products Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Chongqing Zhifei Biological Products Co

Our stock analysis for Chongqing Zhifei Biological Products Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chongqing Zhifei Biological Products Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.